Jean-Marie Jouannic

Dr. Jean-Marie Jouannic


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in The Lancet
Verified
Journal Article
Closed access
JJJean-Marie Jouannic
Jean-Marie Jouannic
SFStephanie Friszer
Stephanie Friszer
ILIsabelle Leparc-Goffart
Isabelle Leparc-Goffart
CGCatherine Garel
Catherine Garel
DEDominique Eyrolle-Guignot
Dominique Eyrolle-Guignot

20 April 2022 in Journal of Medical Internet Research
Verified
Journal Article
Open access
FDFerdinand Dhombres
Ferdinand Dhombres
JBJules Bonnard
Jules Bonnard
KBKévin Bailly
Kévin Bailly
PMPaul Maurice
Paul Maurice
APAris T Papageorghiou
Aris T Papageorghiou
JJJean-Marie Jouannic
Jean-Marie Jouannic
Background: The applications of artificial intelligence (AI) processes have grown significantly in all medical disciplines during the last decades. Two main types of AI have been applied in medicine: symbolic AI (eg, knowledge base and ontologies) and nonsymbolic AI (eg, machine learning and artificial neural networks). Consequently, AI has also been applied across most obstetrics and gynecology (OB/GYN) domains, including general obstetrics, gynecology surgery, fetal ultrasound, and assisted reproductive medicine, among others. Objective: The aim of this study was to provide a systematic review to establish the actual contributions of AI reported in OB/GYN discipline journals. Methods: The PubMed database was searched for citations indexed with “artificial intelligence” and at least one of the following medical subject heading (MeSH) terms between January 1, 2000, and April 30, 2020: “obstetrics”; “gynecology”; “reproductive techniques, assisted”; or “pregnancy.” All publications in OB/GYN core disciplines journals were considered. The selection of journals was based on disciplines defined in Web of Science. The publications were excluded if no AI process was used in the study. Review, editorial, and commentary articles were also excluded. The study analysis comprised (1) classification of publications into OB/GYN domains, (2) description of AI methods, (3) description of AI algorithms, (4) description of data sets, (5) description of AI contributions, and (6) description of the validation of the AI process. Results: The PubMed search retrieved 579 citations and 66 publications met the selection criteria. All OB/GYN subdomains were covered: obstetrics (41%, 27/66), gynecology (3%, 2/66), assisted reproductive medicine (33%, 22/66), early pregnancy (2%, 1/66), and fetal medicine (21%, 14/66). Both machine learning methods (39/66) and knowledge base methods (25/66) were represented. Machine learning used imaging, numerical, and clinical data sets. Knowledge base methods used mostly omics data sets. The actual contributions of AI were method/algorithm development (53%, 35/66), hypothesis generation (42%, 28/66), or software development (3%, 2/66). Validation was performed on one data set (86%, 57/66) and no external validation was reported. We observed a general rising trend in publications related to AI in OB/GYN over the last two decades. Most of these publications (82%, 54/66) remain out of the scope of the usual OB/GYN journals. Conclusions: In OB/GYN discipline journals, mostly preliminary work (eg, proof-of-concept algorithm or method) in AI applied to this discipline is reported and clinical validation remains an unmet prerequisite. Improvement driven by new AI research guidelines is expected. However, these guidelines are covering only a part of AI approaches (nonsymbolic) reported in this review; hence, updates need to be considered.

14 March 2013 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Open access
PDF file
RMR. Mangione
R. Mangione
FDFerdinand Dhombres
Ferdinand Dhombres
NLN. Lelong
N. Lelong
SAS. Amat
S. Amat
FAF. Atoub
F. Atoub
JJJean-Marie Jouannic
Jean-Marie Jouannic
Objective: To evaluate the contribution of examination of specific anatomical features of the fetal posterior brain on mid‐sagittal first‐trimester ultrasound examination to the early detection of open spina bifida.Methods: Four independent observers reviewed a series of 260 mid‐sagittal first‐trimester ultrasound images from 52 cases of open spina bifida and 208 normal fetuses. The following analysis was performed by each reviewer for each image: Herman score calculation, intracranial translucency score (CFEF‐IT) calculation and determination of presence or absence of three anatomical criteria: intracranial translucency (IT), caudal displacement of the brainstem and cisterna magna. The sensitivity and the false‐positive rate for spina bifida detection were calculated for each of the latter three criteria. A secondary analysis was performed on the subset of images achieving a Herman score ≥ 7.Results: The highest detection rate for spina bifida was achieved by non‐visualization of the cisterna magna, with associated sensitivity of 50–73% and 39–76%, respectively, for all images and for the subset of images achieving a Herman score ≥ 7. Posterior shift of the brainstem achieved the highest detection rate (86%), but for a single reviewer only. The level of variation in performance between observers was also greatest for this sign. Absence of IT was associated with a lower detection rate for all observers. Overall, an abnormal posterior brain presenting at least one of these three criteria was associated with a detection rate ranging from 50 to 90%.Conclusion: In the detection of spina bifida, non‐visualization of the cisterna magna achieved the best screening performance. Both non‐visualization of the IT and posterior shift of the brainstem were associated with acceptable but lower detection rates. A prospective evaluation of changes in the posterior brain is needed to allow assessment of the most pertinent criteria for first‐trimester screening for spina bifida. Copyright © 2013 ISUOG. Published by John Wiley & Sons Ltd.

9 June 2020 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Closed access
PDF file
PMP. Maurice
P. Maurice
LGL. Guilbaud
L. Guilbaud
JGJ. Garel
J. Garel
MMM. Mine
M. Mine
ADA. Dugas
A. Dugas
JJJean-Marie Jouannic
Jean-Marie Jouannic

1 May 2017 in Journal of Gynecology Obstetrics and Human Reproduction
Verified
Journal Article
Closed access
PMP. Maurice
P. Maurice
FDFerdinand Dhombres
Ferdinand Dhombres
EBE. Blondiaux
E. Blondiaux
SFS. Friszer
S. Friszer
LGL. Guilbaud
L. Guilbaud
JJJean-Marie Jouannic
Jean-Marie Jouannic

16 October 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
BFBenoit de la Fourniere
Benoit de la Fourniere
FDFerdinand Dhombres
Ferdinand Dhombres
PMPaul Maurice
Paul Maurice
SFSabine de Foucaud
Sabine de Foucaud
PLPauline Lallemant-Dudek
Pauline Lallemant-Dudek
JJJean-Marie Jouannic
Jean-Marie Jouannic
Folic acid supplementation is recommended for neural tube defect prevention during pregnancy. We conducted an observational, retrospective national registry study to determine the rate of dispensing of periconceptional folic acid after prescription in a sample of French women representative of the general population. Our study population (n = 186,061) was a representative sample of the French population, recorded in the Health Data System database on pharmacy dispensing of medication and mandatory reporting of pregnancy. Between 2006 and 2016, 14.3% of pregnant women had a prescription for folic acid supplementation during the month preceding conception and for the first 12 weeks of pregnancy. Of these prescriptions, 30.9% were issued before the start of pregnancy. This percentage was lower for first pregnancies. The rate of pharmacy dispensing during the preconception period increased progressively from 3.8% to 8.3% between 2006 and 2016. In France, the rate of pharmacy dispensing of periconceptional folic acid after medical prescription is very low and does not follow international recommendations. It seems essential to implement awareness-raising policies targeting the general population and physicians regarding effective periconceptional supplementation, particularly starting in the preconception period. Clarification of international recommendations and fortification of flour could improve the efficacy of folate supplementation at population level.